Not Signed In - Ranbaxy Receives Approval To Market Cefprozil Suspension
Mon, 03 Jul 2006 06:00 AM EST
... Ranbaxy Pharmaceuticals Inc.(RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL),announced today that RLL has received approval from the U.S. Food and DrugAdministration to manufacture and market Cefprozil for Oral Suspension USP,125 mg/5mL and 250 mg/5mL. The Office of Generic Drugs, U.S. [click link for full article] ...
Related Topics
- Cefprozil
- Cefprozil Suspension
- Rofecoxib Oral Suspension
- Research
- Aluminum and Magnesium Hydroxide Oral Suspension
- Amoxicillin Oral Suspension
- Cerivastatin - Withdrawn From The Market
- Vaccine Testing & Approval
- Dicloxacillin Suspension
- Carbetapentane, Phenylephrine, and Pyrilamine oral suspension
- Ciprofloxacin Suspension
- Cefpodoxime Suspension
- Tragacanth
- Cefuroxime Suspension
- Cefdinir Suspension
- Erythromycin Oral Suspension
- Carbetapentane and Chlorpheniramine oral suspension
- Megestrol Oral Suspension
- Carbamazepine Suspension
- Oseltamivir Oral Suspension
email this page
print this page
bookmark this page
feedback on this page
